Phibro Animal Health Corp Class A PAHC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference
-
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
-
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results
-
Phibro Animal Health Corporation Declares Quarterly Dividend
-
Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million
Trading Information
- Previous Close Price
- $21.13
- Day Range
- $20.87–21.38
- 52-Week Range
- $9.40–22.84
- Bid/Ask
- $20.66 / $21.31
- Market Cap
- $863.13 Mil
- Volume/Avg
- 178,266 / 167,962
Key Statistics
- Price/Earnings (Normalized)
- 17.91
- Price/Sales
- 0.85
- Dividend Yield (Trailing)
- 2.27%
- Dividend Yield (Forward)
- 2.27%
- Total Yield
- 2.25%
Company Profile
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,940
- Website
- https://www.pahc.com
Comparables
Valuation
|
Metric
|
PAHC
|
ZTS
|
ELAN
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.91 | 34.30 | 16.29 |
Price/Book Value | 3.36 | 17.37 | 1.22 |
Price/Sales | 0.85 | 9.79 | 1.61 |
Price/Cash Flow | 15.85 | 29.83 | 13.42 |
Price/Earnings
PAHC
ZTS
ELAN
Financial Strength
|
Metric
|
PAHC
|
ZTS
|
ELAN
|
|---|---|---|---|
Quick Ratio | 1.39 | 1.64 | 1.09 |
Current Ratio | 2.94 | 3.45 | 2.93 |
Interest Coverage | 1.29 | 12.68 | −3.61 |
Quick Ratio
PAHC
ZTS
ELAN
Profitability
|
Metric
|
PAHC
|
ZTS
|
ELAN
|
|---|---|---|---|
Return on Assets (Normalized) | 4.97% | 18.00% | 3.06% |
Return on Equity (Normalized) | 17.87% | 51.43% | 6.97% |
Return on Invested Capital (Normalized) | 7.89% | 22.69% | 5.38% |
Return on Assets
PAHC
ZTS
ELAN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fsdtrqcjc | Rnl | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Qcgdwxxyj | Vthwgqt | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Qwswdjq | Xhph | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Gqwjwfvc | Pcfzm | $19.9 Bil | |||
| Viatris Inc
VTRS
| Nsmxkjky | Fspp | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vrlfnys | Cxcr | $13.4 Bil | |||
| Catalent Inc
CTLT
| Dqdhcst | Fmjdhy | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Hvhtsfqfy | Wtcknl | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Mwkvrjnv | Bdqnv | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Lxlvpxrd | Xrjk | $2.5 Bil |
United States